Decreased Low Back Pain Intensity and Differential Gene Expression Following Calmare®: Results From a Double-Blinded Randomized Sham-Controlled Study

Research in Nursing and Health

Volumn 38, Issue 1, 2015, Pages 29-38

  Starkweather, Angela R ^a   Coyne, Patrick ^a   Lyon, Debra E ^b   Elswick, R K ^a   An, Kyungeh ^a   Sturgill, Jamie ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Calmare ; Chronic pain; Gene expression; Low back pain; Scrambler

Indexed keywords

ADOLESCENT; ADULT; ANALGESIA; CHRONIC PAIN; CONTROLLED STUDY; DEVICES; DOUBLE BLIND PROCEDURE; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; LOW BACK PAIN; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHRONIC PAIN; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; PAIN MANAGEMENT; PAIN MEASUREMENT; PAIN THRESHOLD; SEVERITY OF ILLNESS INDEX; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME;

EID: 84921026528     PISSN: 01606891     EISSN: 1098240X     Source Type: Journal    
DOI: 10.1002/nur.21632     Document Type: Article

References (38)

1. Attur, M., Belitskaya-Levy, I., Oh, C., Krasnokutsky, S., Greenberg, J., Samuels, J. ... Abramson, S. B. (2011). Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk of progression of symptomatic knee osteoarthritis. Arthritis & Rheumatology, 63, 1908-1917. doi: 10.1002/art.30360
2. Bell, J. T., Loomis, A. K., Butcher, L. M., Gao, F., Zhang, B., Hyde, C. L. ... Zondervan, L. (2014). Differential methylation of the TRPA1 promoter in pain sensitivity. Nature Communications, 5, 1-11. doi: 10.1038/ncomms3978
3. Benedetti, F. (2009). Placebo effects: Understanding the mechanisms in health and disease. New York: Oxford University Press.
4. Burgoyne, D. S. (2007). Prevalence and economic implications of chronic pain. Managed Care, 16, 2-4.
5. Cavalcante Miranda de Assis, D., Martins Lima, E., Teixeira Goes, B., Zugaib Cavalcanti, J., Barbosa Paixao, A., Vannier-Santos, M. A. ...Baptista, A. F. (2014). The parameters of trancutanous electrical nerve stimulation are critical to its regenerative effects when applied just after a sciatic crush lesion in mice. Biomedical Research International, Article 572949, 1-8.
6. Chesterton, L. S., Sim, J., Wright, C. C., & Foster, N. E. (2007). Interrater reliability of algometry in measuring pressure pain thresholds in health humans using multiple raters. Clinical Journal of Pain, 23, 760-767.
7. Chou, R., & Huffman, L. H. (2007). Guideline for the evaluation and management of low back pain: Evidence review. Glenview, IL: American Pain Society.
8. Clauw, D. J., Williams, D., Lauerman, W., Dahlman, M., Aslami, A., Nachemson, A. L. ... Wiesel, S. W. (1999). Pain sensitivity as a correlate of clinical status in individuals with chronic low back pain. Spine, 24, 2035-2041. doi: 10.1097/00007632-199910010-00013
9. Cleeland, C.S. (2009). The Brief Pain Inventory user guide. (pp. 1-9). Houston: M. D Anderson Cancer Center.
10. Coyne, P. J., Wan, W., Dodson, P., Swainey, C., & Smith, T. J. (2013). A trial of scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy. Journal of Pain and Palliative Care Pharmacotherapy, 27, 359-364. doi: 10.3109/15360288.2013.847519
11. Dworkin, R. H., Turk, D. C., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Katz, N. ... Witter, J. (2005). Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain, 113, 9-19.
12. Emery, E. C., Young, G. T., Berrocoso, E. M., Chen, L., & McNaughton, P. A. (2011). HCN2 ion channels play a central role in inflammatory and neuropathic pain. Science, 333, 1462-1466. doi: 10.1126/science.1206243
13. Fang, J. F., Liang, Y., Du, J. Y., & Fang, J. Q. (2013). Transcutaneous electrical nerve stimulation attenuates CFA-induced hyperalgesia and inhibits spinal ERK1/2-COX-2 pathway activation in rats. BMC Complementary and Alternative Medicine, 13, 134. doi: 10.1186/1472-6882-13-134
14. Freburger, J. K., Holmes, G. M., Agans, R. P., Jackman, A. M., Darter, J. D., Wallace, A. ... Carey, T. S. (2009). The rising prevalence of chronic low back pain. Archives of Internal Medicine, 169, 251-258. doi: 10.1001/archinternmed.2008.543
15. Giesecke, T., Gracely, R. H., Grant, M. A. B., Nachemson, A., Petzke, F., Williams, D. A., & Clauw, D. J. (2004). Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis and Rheumatism, 50, 613-623.
16. Gold, M. S., & Gebhart, G. F. (2010). Nociceptor sensitization in pain pathogenesis. Nature Medicine, 16, 1248-1257. doi: 10.1038/nm.2235
17. Gracely, R. H. (2005). Evaluation of pain sensations. In: H. Merskey, J. D. Loeser, & R. Dubner (Eds.), The paths of pain. (pp. 271-284). Seattle: International Association for the Study of Pain Press.
18. Hedeker, D., & Gibbons, R. D. (2006). Longitudinal data analysis. Hoboken, NJ: John Wiley & Sons.
19. Hulse, R. P., Donaldson, L. F., & Wynick, D. (2012). Peripheral galanin receptor 2 as a target for the modulation of pain. Pain Research and Treatment, Article 545386. doi: http://dx.doi.org/10.1155/2012/545386 .
20. Institute of Medicine. (2011). Relieving pain in America: A blueprint for transforming prevention, care, education and research. Washington, DC: The National Academies Press.
21. Jacobsen, L. M., Eriksen, G. S., Pedersen, L. M., & Gjerstad, J. (2010). Catechol-O-methyltransferase (COMT) inhibition reduces spinal nociceptive activity. Neuroscience Letters, 473, 212-215. doi: 10.1016/j.neulet.2010.02.049
22. Jankowski, M. P., & Koerber, R. (2010). Neurotrophic factors and nociceptor sensitization. In: M. P. Jankowski & H. R. Koerber (Eds.), Translational pain research: From mouse to man. (pp. 31-50). Boca Raton, FL: CRC Press.
23. Keller, S., Bann, C. M., Dodd, S. L., Schein, J., Mendoza, T. R., & Cleeland, C. S. (2004). Validity of the Brief Pain Inventory for use in documenting the outcomes of patients with noncancer pain. Clinical Journal of Pain, 20, 309-318.
24. Malin, S. A., Molliver, D. C., Koerber, H. R., Cornuet, P., Frye, R., Albers, K. M., & Davis, B. M. (2006). Glial cell line-derived neurotrophic factor family members sensitize nociceptors in vitro and produce thermal hyperalgesia in vivo. Journal of Neuroscience, 26, 8588-8599.
25. Marineo, G., Iorno, V., Gandini, C., Moschini, V., & Smith, T. J. (2012). Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: Results of a pilot, randomized, controlled trial. Journal of Pain and Symptom Management, 43, 87-95. doi: 10.1016/j.jpainsymman.2011.03.015
26. Moss, P., Sluka, K., & Wright, A. (2007). The initial effects of knee joint mobilization on osteoarthritic hyperalgesia. Manual Therapies, 12, 109-118. doi: 10.1016/j.math.2006.02.009
27. Nicol, G. D., & Vasko, M. R. (2007). Unraveling the story of NGF-mediated sensitization of nociceptive sensory neurons: ON or OFF the Trks? Molecular Interventions, 7, 26-41.
28. O'Neill, S., Manniche, C., Graven-Nielsen, T., & Arendt-Nielsen, L. (2007). Generalized deep tissue hyperalgesia in patients with chronic low back pain. European Journal of Pain, 11, 415-420. doi: 10.1016/j.ejpain.2006.05.009
29. Pezet, S., & McMahon, S. B. (2006). Neurotrophins: Mediators and modulators of pain. Annual Review of Neuroscience, 29, 507-538. doi: 10.1146/annurev.neuro.29.051605.112929
30. Ren, K., & Dubner, R. (2007). Pain facilitation and activity-dependent plasticity in pain modulatory circuitry: Role of BDNF-TrkB signaling and NMDA receptors. Molecular Neurobiology, 35, 224-235. doi: 10.1007/s12035-007-0028-8
31. Ricci, M., Pirotti, S., Scarpi, E., Burgio, M., Maltoni, M., Sansoni, E., & Amadori, D. (2011). Managing chronic pain: Results from an open-label study using MC5-A Calmare device. Supportive Care in Cancer, 20, 405-412.
32. Rolke, R., Magerl, W., Campbell, A., Schalber, C., Caspari, S., Birklein, F., & Treed, R. D. (2006). Quantitative sensory testing: A comprehensive protocol for clinical trials. European Journal of Pain, 10, 77-88.
33. Sabato, A. F., Marineo, G., & Gatti, A. (2005). Calmare therapy. Minverva Anestesiologica, 71, 479-482.
34. Smith, T. J., Coyne, P. J., Parker, G. L., Dodson, P., & Ramakrishnan, V. (2010). Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare) for chemotherapy-induced peripheral neuropathy. Journal of Pain and Symptom Management, 40, 883-891. doi: 10.1016/j.jpainsymman.2010.03.022
35. Smith, T. J., & Marineo, G. (2013). Treatment of postherpetic pain with Calmare therapy, a patient-specific neurocutaneous electrical stimulation device. American Journal of Hospice and Palliative Care (Advance online publication). doi: 10.1177/1049909113494002
36. Soni, A. (2011). Top 10 most costly conditions among men and women 2008: Estimates for the U.S. civilian noninstitutionalized adult population, age 18 and older. Medical Expenditure Panel Survey (MEPS) Statistical Brief #331. Rockville, MD: AHRQ.
37. Weinkauf, B., Obreja, O., Schmelz, M., & Rukwied, R. (2014). Differential time course of NGF-induced hyperalgesia to heat versus mechanical and electrical stimulation in human skin. European Journal of Pain (Advance online publication). doi: 10.1002/ejp.603 [Online ahead of print].
38. Yang, L., Yang, L., & Gao, X. (2010). Transcutaneous electrical nerve stimulation on Yongquan acupoint reduces CFA-induced thermal hyperalgesia of rats via down-regulation of ERK2 phosphorylation and c-fos expression. The Anatomical Record, 293, 1207-1213. doi: 10.1002/ar.21157